PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

amikacin

Verify with FDA → · CMS NADAC pricing →

Brand names: Amikin

Aminoglycoside Antibiotic Rx

Amikacin is an antibiotic medicine. It fights serious infections caused by certain types of bacteria.

What it does

Amikacin treats serious infections caused by bacteria.

Common side effects

No common side effects listed.

Key warnings

Amikacin can potentially cause hearing loss and kidney damage.

How It Works

Amikacin belongs to a class of drugs called aminoglycosides. It works by stopping the growth of bacteria. This helps your body fight off the infection.

How to Take It

Amikacin is given as an injection into a muscle or vein. Your doctor will decide the right dose for you based on your weight and kidney function. It is usually given 2 or 3 times a day. Treatment usually lasts 7 to 10 days.

Pregnancy & Breastfeeding

Tell your doctor if you are pregnant or breastfeeding. Amikacin may harm your unborn baby. It is not known if amikacin passes into breast milk.

Missed Dose

Call your doctor right away if you miss a dose. They will tell you when to get your next injection.

Storage

Store at room temperature between 68° to 77°F (20° to 25°C).

Side Effects (from patient reports)

Based on 12,996 FDA adverse event reports.

Off Label Use
1,908
Drug Ineffective
1,673
Cough
1,620
Dyspnoea
1,556
Hospitalisation
1,360
Therapy Interrupted
1,348
Death
1,103
Dysphonia
977
Product Dose Omission Issue
730
Nausea
721

FDA Adverse Event Report Analysis

Detailed analysis of 16,238 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.

Total Reports

16,238

Death-Related Reports

3,283

Hospitalization Reports

6,935

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 8,081 (54%)
Male 6,794 (46%)

Age Distribution

0–17 1,599
18–44 2,124
45–64 2,877
65–74 1,996
75+ 1,556

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 OFF LABEL USE 1,908
2 DRUG INEFFECTIVE 1,673
3 COUGH 1,620
4 DYSPNOEA 1,556
5 HOSPITALISATION 1,360
6 THERAPY INTERRUPTED 1,348
7 DEATH 1,103
8 DYSPHONIA 977
9 PRODUCT DOSE OMISSION ISSUE 730
10 NAUSEA 721
11 FATIGUE 702
12 PNEUMONIA 649
13 DIARRHOEA 634
14 PYREXIA 632
15 PRODUCTIVE COUGH 598

Reactions in Death Reports

DEATH 1,103
DRUG INEFFECTIVE 553
OFF LABEL USE 330
DYSPNOEA 277
SEPTIC SHOCK 266
THERAPY INTERRUPTED 220
PNEUMONIA 214
MULTIPLE ORGAN DYSFUNCTION SYNDROME 203
HOSPITALISATION 189
COUGH 188

Reactions in Hospitalization Reports

HOSPITALISATION 1,360
THERAPY INTERRUPTED 1,038
OFF LABEL USE 826
DYSPNOEA 821
DRUG INEFFECTIVE 799
COUGH 741
PNEUMONIA 519
PRODUCT DOSE OMISSION ISSUE 465
PYREXIA 423
DEATH 401

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

Amikacin can potentially cause hearing loss and kidney damage. Tell your doctor if you have kidney problems or are taking other medicines that can affect your hearing or kidneys. Your doctor should closely monitor you for hearing and kidney problems during treatment. This drug can also cause muscle weakness or breathing problems, especially if you are also taking anesthesia or certain muscle relaxants.

Known Drug Interactions

Nephrotoxic agents Concomitant administration of cidofovir injection and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and amikacin), amphotericin B, foscarnet, intravenous pentamidine, vancomycin, and nonsteroidal anti-inflammatory agents] is contraindicated.

Mechanism: Both of these drugs can be harmful to the kidneys. Using them together significantly increases the chance of kidney injury.

What to do: You should not take these medicines together. Your doctor will need to change your treatment plan to avoid this combination.

ZOSYN, which contains EDTA, is compatible with amikacin and gentamicin for simultaneous Y-site infusion in certain diluents and at specific concentrations.

Mechanism: These two drugs can be given through the same IV line at the same time as long as they are mixed in specific liquids and at certain strengths.

What to do: Your healthcare provider should follow specific mixing instructions to ensure both medications remain safe and effective.

Common Questions

How long will I need to take amikacin?
The usual treatment time is 7 to 10 days.
What tests will be done while I am taking amikacin?
Your doctor will check your kidney function and hearing.
Can amikacin affect my hearing?
Yes, amikacin can cause hearing loss.
Can amikacin affect my kidneys?
Yes, amikacin can cause kidney damage.
What should I do if I experience dizziness or hearing changes?
Tell your doctor right away if you have dizziness or hearing changes.
Can I take amikacin if I am allergic to other antibiotics?
Tell your doctor if you are allergic to any antibiotics, especially aminoglycosides.
Will amikacin interact with other medications I am taking?
Tell your doctor about all the medicines you take, including over-the-counter drugs and supplements.
How will I know if the amikacin is working?
Your doctor will monitor your infection to see if it is improving.
Are there any long-term side effects of amikacin?
Hearing loss from amikacin may be permanent.
When should I call my doctor?
Call your doctor if your symptoms get worse or if you experience any new or concerning symptoms.
Does amikacin interact with other medications?
Yes, amikacin has 2 known drug interactions. Notable interactions include cidofovir, piperacillin/tazobactam. Always inform your doctor about all medications you are taking.
What drug class is amikacin?
amikacin belongs to the Aminoglycoside Antibiotic drug class. It requires a prescription (Rx). Amikacin treats serious infections caused by bacteria.
Is amikacin safe during pregnancy?
Tell your doctor if you are pregnant or breastfeeding. Amikacin may harm your unborn baby. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.

Related Medications in Aminoglycoside Antibiotic

Other drugs grouped near amikacin — same-class peers and common alternatives.

Compare amikacin vs amoxicillin side-by-side →

Medication Guides

Related Health & Safety Data

Save on amikacin

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for amikacin

The FDA label for amikacin (sold under brand names such as Amikin) classifies it as a prescription-only medication in the Aminoglycoside Antibiotic class. Amikacin treats serious infections caused by bacteria. Labeling covers dosing, contraindications, and monitoring requirements derived from clinical trials.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 12,996 voluntary reports. The database also lists 2 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. Acquisition-cost data is surveyed weekly by CMS and updated as manufacturers report changes.

Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: April 8, 2024

All federal data sources used on this page